Up‐regulation and clinical significance of serine protease kallikrein 6 in colon cancer

Kallikrein‐related peptidase 6 (KLK6) encodes a trypsin‐like serine protease that is up‐regulated in several cancers, although the putative functions of KLK6 in cancer have not been elucidated. In the current study, overexpression of KLK6 was identified in colon cancer, and the possibility that KLK6 may be a suitable candidate as a tumor marker was examined.

[1]  James R. Miller,et al.  Zyme, a Novel and Potentially Amyloidogenic Enzyme cDNA Isolated from Alzheimer’s Disease Brain* , 1997, The Journal of Biological Chemistry.

[2]  T. Salo,et al.  Proteolytic degradation of extracellular matrix in tumor invasion. , 1987, Biochimica et biophysica acta.

[3]  Steven M. Thompson,et al.  Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals That a Trypsin-like Kallikrein Is Expressed in the Central Nervous System* , 2002, The Journal of Biological Chemistry.

[4]  T. Tanaka,et al.  Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. , 1997, Biochimica et biophysica acta.

[5]  C. Cordon-Cardo,et al.  Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. , 2003, Cancer research.

[6]  J. Oesterling,et al.  Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. , 1995, Urology.

[7]  U. Stenman.  New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease. , 1999, Clinical chemistry.

[8]  Bonnie F. Sloane,et al.  Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. , 2008, Neoplasia.

[9]  E. Diamandis,et al.  Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer , 2005, Clinical Cancer Research.

[10]  T. Utsunomiya,et al.  Clinical Significance of Human Kallikrein Gene 6 Messenger RNA Expression in Colorectal Cancer , 2005, Clinical Cancer Research.

[11]  K. Shigemasa,et al.  Increased Expression of Protease M in Ovarian Tumors , 1999, Tumor Biology.

[12]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[13]  S. Mok,et al.  A Novel Protease Homolog Differentially Expressed in Breast and Ovarian Cancer , 1996, Molecular medicine.

[14]  W. Birchmeier,et al.  Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.

[15]  M. Takeichi.  Cadherins in cancer: implications for invasion and metastasis. , 1993, Current opinion in cell biology.

[16]  G. Yousef,et al.  Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. , 2000, Clinical biochemistry.

[17]  A. Vlahou,et al.  A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. , 2009, Cancer research.

[18]  A. Partin,et al.  Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. , 1998, Critical reviews in clinical laboratory sciences.

[19]  S W Scherer,et al.  Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. , 1999, Genomics.

[20]  E. Diamandis,et al.  The emerging roles of human tissue kallikreins in cancer , 2004, Nature Reviews Cancer.

[21]  L. Liotta,et al.  General mechanisms of metastasis , 1997, Cancer.

[22]  D. Katsaros,et al.  Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  G. Yousef,et al.  Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. , 2000, Clinical biochemistry.

[24]  John H. White,et al.  Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. , 2002, Molecular endocrinology.

[25]  S. Mok,et al.  Characterisation of human kallikrein 6/protease M expression in ovarian cancer , 2004, British Journal of Cancer.

[26]  À. Bayés,et al.  Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation , 2004, Biological chemistry.

[27]  K. Wang,et al.  Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. , 2000, Gene.

[28]  E. Diamandis,et al.  Characterization of Human Kallikreins 6 and 10 in Ascites Fluid from Ovarian Cancer Patients , 2006, Tumor Biology.

[29]  G. Yousef,et al.  The new human tissue kallikrein gene family: structure, function, and association to disease. , 2001, Endocrine reviews.

[30]  G. Yousef,et al.  In-silico analysis of kallikrein gene expression in pancreatic and colon cancers. , 2004, Anticancer research.

[31]  T. Utsunomiya,et al.  Clinicopathologic and Biological Significance of Kallikrein 6 Overexpression in Human Gastric Cancer , 2005, Clinical Cancer Research.

[32]  E. Diamandis,et al.  Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. , 2003, Biochemical and biophysical research communications.

[33]  E. Diamandis,et al.  Human tissue kallikreins: physiologic roles and applications in cancer. , 2004, Molecular cancer research : MCR.

[34]  Miltiadis Paliouras,et al.  Human tissue kallikreins: the cancer biomarker family. , 2007, Cancer letters.